ePRO for the Timely Detection of Side Effects in Cancer Patients Undergoing CAR T Immunotherapy
Recruiting
- Conditions
- CAR T-Cell TherapyPatient Reported Outcome Measures
- Interventions
- Device: Consilium CareTM
- First Posted Date
- 2022-05-02
- Last Posted Date
- 2024-04-19
- Lead Sponsor
- Stiftung Swiss Tumor Institute
- Target Recruit Count
- 11
- Registration Number
- NCT05354973
- Locations
- 🇨🇭
Klinik für Hämatologie und Onkologie, Zürich, Switzerland
The Possible Influence of Different Follow-up Modalities on Overall Survival in Ovarian Cancer
Terminated
- Conditions
- Patient Reported Outcome MeasuresOvarian Neoplasms
- First Posted Date
- 2022-04-28
- Last Posted Date
- 2024-04-22
- Lead Sponsor
- Stiftung Swiss Tumor Institute
- Target Recruit Count
- 7
- Registration Number
- NCT05352217
- Locations
- 🇨🇭
Spital Limmattal Frauenklinik, Schlieren, Zürich, Switzerland
🇨🇭Gynäkologische Onkologie Spital Zollikerberg, Zollikerberg, Zürich, Switzerland
🇨🇭Interdisziplinäre Medizin Zürich (IMZ), Zürich, Switzerland
© Copyright 2025. All Rights Reserved by MedPath